A brief history of tumor necrosis factor α - converting enzyme: An overview of ectodomain shedding

Keio Journal of Medicine

Volumn 62, Issue 1, 2013, Pages 29-36

  Horiuchi, Keisuke ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Ectodomain shedding; TACE ADAM17; TNF

Indexed keywords

ADAM PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; L SELECTIN; LIPOPOLYSACCHARIDE; METALLOPROTEINASE INHIBITOR; TRANSCRIPTION FACTOR SOX9; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; VASCULOTROPIN RECEPTOR 2;

ASTHMA; BONE DEVELOPMENT; CHEMICAL ANALYSIS; CROHN DISEASE; ENZYME MECHANISM; GENE MUTATION; GROWTH RETARDATION; HEMATOPOIETIC SYSTEM; HOMEOSTASIS; HUMAN; IMMUNOPATHOLOGY; MACROPHAGE; MONOCYTE; NONHUMAN; PHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

ADAM PROTEINS; ANIMALS; ANTIGENS, CD44; GENE EXPRESSION; HUMANS; L-SELECTIN; LIGANDS; MICE; MICE, KNOCKOUT; PROTEIN PRECURSORS; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84875665674     PISSN: 00229717     EISSN: 18801293     Source Type: Journal    
DOI: 10.2302/kjm.2012-0003-RE     Document Type: Review

References (60)

1. Murphy G: The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer 2008; 8: 929-941. [Medline] [CrossRef]
2. Murphy G, Murthy A, Khokha R: Clipping, shedding and RIP-ping keep immunity on cue. Trends Immunol 2008; 29: 75-82. [Medline] [CrossRef]
3. Dreymueller D, Pruessmeyer J, Groth E, Ludwig A: The role of AD-AM-mediated shedding in vascular biology. Eur J Cell Biol 2012; 91: 472-485.
4. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP: A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997; 385: 729-733. [Medline] [CrossRef]
5. Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Becherer JD: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997; 385: 733-736. [Medline] [CrossRef]
6. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP: Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 2004; 164: 769-779. [Medline] [CrossRef]
7. Blobel CP: ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 2005; 6: 32-43. [Medline] [CrossRef]
8. Scott DL, Kingsley GH: Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med 2006; 355: 704-712. [Medline] [CrossRef]
9. Kenny PA: TACE: a new target in epidermal growth factor receptor dependent tumors. Differentiation 2007; 75: 800-808. [Medline] [CrossRef]
10. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975; 72: 3666-3670. [Medline] [CrossRef]
11. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV: Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984; 312: 724-729. [Medline] [CrossRef]
12. Kriegler M, Perez C, DeFay K, Albert I, Lu SD: A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell 1988; 53: 45-53. [Medline] [CrossRef]
13. McGeehan GM, Becherer JD, Bast RC Jr, Boyer CM, Champion B, Connolly KM, Conway JG, Furdon P, Karp S, Kidao S, McElroy AB, Nichols J, Pryzwansky KM, Schoenen F, Sekut L, Truesdale A, Verghese M, Warner J, Ways JP: Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature 1994; 370: 558-561. [Medline] [CrossRef]
14. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, et al: Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 1994; 370: 555-557. [Medline] [CrossRef]
15. Mohler KM, Sleath PR, Fitzner JN, Cerretti DP, Alderson M, Kerwar SS, Torrance DS, Otten-Evans C, Greenstreet T, Weerawarna K, et al: Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 1994; 370: 218-220. [Medline] [CrossRef]
16. Ruuls SR, Hoek RM, Ngo VN, McNeil T, Lucian LA, Janatpour MJ, Korner H, Scheerens H, Hessel EM, Cyster JG, McEvoy LM, Sedgwick JD: Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 2001; 15: 533-543. [Medline] [CrossRef]
17. Haro H, Crawford HC, Fingleton B, Shinomiya K, Spengler DM, Matrisian LM: Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J Clin Invest 2000; 105: 143-150. [Medline] [CrossRef]
18. Rosendahl MS, Ko SC, Long DL, Brewer MT, Rosenzweig B, Hedl E, Anderson L, Pyle SM, Moreland J, Meyers MA, Kohno T, Lyons D, Lichenstein HS: Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases. J Biol Chem 1997; 272: 24588-24593. [Medline] [CrossRef]
19. Zheng Y, Saftig P, Hartmann D, Blobel C: Evaluation of the contribution of different ADAMs to tumor necrosis factor alpha (TN-Falpha) shedding and of the function of the TNFalpha ectodomain in ensuring selective stimulated shedding by the TNFalpha convertase (TACE/ADAM17). J Biol Chem 2004; 279: 42898-42906. [Medline] [CrossRef]
20. Coeshott C, Ohnemus C, Pilyavskaya A, Ross S, Wieczorek M, Kroona H, Leimer AH, Cheronis J: Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci USA 1999; 96: 6261-6266. [Medline] [CrossRef]
21. Marino MW, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada H, Moore M, Williamson B, Basu S, Old LJ: Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 1997; 94: 8093-8098. [Medline] [CrossRef]
22. Peschon JJ, Torrance DS, Stocking KL, Glaccum MB, Otten C, Willis CR, Charrier K, Morrissey PJ, Ware CB, Mohler KM: TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 1998; 160: 943-952. [Medline]
23. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black RA: An essential role for ectodomain shedding in mammalian development. Science 1998; 282: 1281-1284. [Medline] [CrossRef]
24. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, et al: Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 1995; 269: 230-234. [Medline] [CrossRef]
25. Sibilia M, Wagner EF: Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 1995; 269: 234-238. [Medline] [CrossRef]
26. Harris RC, Chung E, Coffey RJ: EGF receptor ligands. Exp Cell Res 2003; 284: 2-13. [Medline] [CrossRef]
27. Luetteke NC, Qiu TH, Peiffer RL, Oliver P, Smithies O, Lee DC: TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 1993; 73: 263-278. [Medline] [CrossRef]
28. Jackson LF, Qiu TH, Sunnarborg SW, Chang A, Zhang C, Patterson C, Lee DC: Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J 2003; 22: 2704-2716. [Medline] [CrossRef]
29. Horiuchi K, Kimura T, Miyamoto T, Takaishi H, Okada Y, Toyama Y, Blobel CP: TNFalpha-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J Immunol 2007; 179: 2686-2689. [Medline]
30. Grivennikov SI, Tumanov AV, Liepinsh DJ, Kruglov AA, Marakusha BI, Shakhov AN, Murakami T, Drutskaya LN, Forster I, Clausen BE, Tessarollo L, Ryffel B, Kuprash DV, Nedospasov SA: Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages/neutrophils: protective and deleterious effects. Immunity 2005; 22: 93-104. [Medline]
31. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I: Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 1999; 8: 265-277. [Medline] [CrossRef]
32. Horiuchi K, Kimura T, Miyamoto T, Miyamoto K, Akiyama H, Takaishi H, Morioka H, Nakamura T, Okada H, Blobel CP, Toyama Y: Conditional inactivation of TACE by a Sox9 promoter leads to osteoporosis and increased granulopoiesis via dysregulation of IL-17 and G-CSF. J Immunol 2009; 182: 2093-2101. [Medline] [CrossRef]
33. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B: The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 2002; 16: 2813-2828. [Medline] [CrossRef]
34. Akiyama H, Kim JE, Nakashima K, Balmes G, Iwai N, Deng JM, Zhang Z, Martin JF, Behringer RR, Nakamura T, de Crombrugghe B: Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc Natl Acad Sci USA 2005; 102: 14665-14670. [Medline] [CrossRef]
35. Blaydon DC, Biancheri P, Di WL, Plagnol V, Cabral RM, Brooke MA, van Heel DA, Ruschendorf F, Toynbee M, Walne A, O'Toole EA, Martin JE, Lindley K, Vulliamy T, Abrams DJ, MacDonald TT, Harper JI, Kelsell DP: Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med 2011; 365: 1502-1508. [Medline] [CrossRef]
36. Weskamp G, Mendelson K, Swendeman S, Le Gall S, Ma Y, Lyman S, Hinoki A, Eguchi S, Guaiquil V, Horiuchi K, Blobel CP: Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes. Circ Res 2010; 106: 932-940. [Medline] [CrossRef]
37. Horiuchi K, Le Gall S, Schulte M, Yamaguchi T, Reiss K, Murphy G, Toyama Y, Hartmann D, Saftig P, Blobel CP: Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol Biol Cell 2007; 18: 176-188. [Medline] [CrossRef]
38. Overall CM, Blobel CP: In search of partners: linking extracellular proteases to substrates. Nat Rev Mol Cell Biol 2007; 8: 245-257. [Medline] [CrossRef]
39. McIlwain DR, Lang PA, Maretzky T, Hamada K, Ohishi K, Maney SK, Berger T, Murthy A, Duncan G, Xu HC, Lang KS, Haussinger D, Wakeham A, Itie-Youten A, Khokha R, Ohashi PS, Blobel CP, Mak TW: iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science 2012; 335: 229-232. [Medline] [CrossRef]
40. Adrain C, Zettl M, Christova Y, Taylor N, Freeman M: Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 2012; 335: 225-228. [Medline] [CrossRef]
41. Fischer OM, Hart S, Gschwind A, Prenzel N, Ullrich A: Oxidative and osmotic stress signaling in tumor cells is mediated by ADAM proteases and heparin-binding epidermal growth factor. Mol Cell Biol 2004; 24: 5172-5183. [Medline] [CrossRef]
42. Hart S, Fischer OM, Ullrich A: Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res 2004; 64: 1943-1950. [Medline] [CrossRef]
43. Le Gall SM, Maretzky T, Issuree PD, Niu XD, Reiss K, Saftig P, Khokha R, Lundell D, Blobel CP: ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site. J Cell Sci 2010; 123: 3913-3922. [Medline] [CrossRef]
44. Horiuchi K, Toyama Y: Posttranslational regulation of cell-surface colony-stimulating factor-1. Crit Rev Immunol 2008; 28: 215-227. [Medline]
45. Horiuchi K, Miyamoto T, Takaishi H, Hakozaki A, Kosaki N, Miyauchi Y, Furukawa M, Takito J, Kaneko H, Matsuzaki K, Morioka H, Blobel CP, Toyama Y: Cell surface colony-stimulating factor 1 can be cleaved by TNF-alpha converting enzyme or endocytosed in a clathrin-dependent manner. J Immunol 2007; 179: 6715-6724. [Medline]
46. Cruz AC, Frank BT, Edwards ST, Dazin PF, Peschon JJ, Fang KC: Tumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells. J Biol Chem 2004; 279: 5612-5620. [Medline] [CrossRef]
47. Swendeman S, Mendelson K, Weskamp G, Horiuchi K, Deutsch U, Scherle P, Hooper A, Rafii S, Blobel CP: VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signaling. Circ Res 2008; 103: 916-918. [Medline] [CrossRef]
48. Chalaris A, Rabe B, Paliga K, Lange H, Laskay T, Fielding CA, Jones SA, Rose-John S, Scheller J: Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory transsignaling function of neutrophils. Blood 2007; 110: 1748-1755. [Medline] [CrossRef]
49. Glomski K, Monette S, Manova K, De Strooper B, Saftig P, Blobel CP: Deletion of Adam10 in endothelial cells leads to defects in organ-specific vascular structures. Blood 2011; 118: 1163-1174. [Medline] [CrossRef]
50. Weber S, Niessen MT, Prox J, Lullmann-Rauch R, Schmitz A, Schwanbeck R, Blobel CP, Jorissen E, de Strooper B, Niessen CM, Saftig P: The disintegrin/metalloproteinase Adam10 is essential for epidermal integrity and Notch-mediated signaling. Development 2011; 138: 495-505. [Medline] [CrossRef]
51. Yoda M, Kimura T, Tohmonda T, Uchikawa S, Koba T, Takito J, Morioka H, Matsumoto M, Link DC, Chiba K, Okada Y, Toyama Y, Horiuchi K: Dual functions of cell-autonomous and non-cellautonomous ADAM10 activity in granulopoiesis. Blood 2011; 118: 6939-6942. [Medline] [CrossRef]
52. Kuhn PH, Wang H, Dislich B, Colombo A, Zeitschel U, Ellwart JW, Kremmer E, Rossner S, Lichtenthaler SF: ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J 2010; 29: 3020-3032. [Medline] [CrossRef]
53. Maretzky T, Reiss K, Ludwig A, Buchholz J, Scholz F, Proksch E, de Strooper B, Hartmann D, Saftig P: ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci USA 2005; 102: 9182-9187. [Medline] [CrossRef]
54. Reiss K, Maretzky T, Ludwig A, Tousseyn T, de Strooper B, Hartmann D, Saftig P: ADAM10 cleavage of N-cadherin and regu-lation of cell-cell adhesion and beta-catenin nuclear signalling. EMBO J 2005; 24: 742-752. [Medline] [CrossRef]
55. Kaneko H, Anzai T, Horiuchi K, Morimoto K, Anzai A, Nagai T, Sugano Y, Maekawa Y, Itoh H, Yoshikawa T, Okada Y, Ogawa S, Fukuda K: Tumor necrosis factor-alpha converting enzyme inactivation ameliorates high-fat diet-induced insulin resistance and altered energy homeostasis. Circ J 2011; 75: 2482-2490. [Medline] [CrossRef]
56. Kaneko H, Anzai T, Horiuchi K, Kohno T, Nagai T, Anzai A, Takahashi T, Sasaki A, Shimoda M, Maekawa Y, Shimizu H, Yoshikawa T, Okada Y, Yozu R, Fukuda K: Tumor necrosis factoralpha converting enzyme is a key mediator of abdominal aortic aneurysm development. Atherosclerosis 2011; 218: 470-478. [Medline] [CrossRef]
57. Dreymueller D, Martin C, Kogel T, Pruessmeyer J, Hess FM, Horiuchi K, Uhlig S, Ludwig A: Lung endothelial ADAM17 regulates the acute inflammatory response to lipopolysaccharide. EMBO Molecular Medicine 2012.(in press).
58. La Marca R, Cerri F, Horiuchi K, Bachi A, Feltri ML, Wrabetz L, Blobel CP, Quattrini A, Salzer JL, Taveggia C: TACE (ADAM17) inhibits Schwann cell myelination. Nat Neurosci 2011; 14: 857-865. [Medline] [CrossRef]
59. Arndt PG, Strahan B, Wang Y, Long C, Horiuchi K, Walcheck B: Leukocyte ADAM17 regulates acute pulmonary inflammation. PLoS ONE 2011; 6: e19938. [Medline] [CrossRef]
60. Long C, Wang Y, Herrera AH, Horiuchi K, Walcheck B: In vivo role of leukocyte ADAM17 in the inflammatory and host responses during E. coli-mediated peritonitis. J Leukoc Biol 2010; 87: 1097-1101. [Medline] [CrossRef]